John Beary III

Master's Degree, Georgetown University 1988 (Business Administration )

Medical Degree, Harvard Medical School 1973

Internship, Johns Hopkins Hospital 1974 (Osler Medical Service)

Residency , Johns Hopkins Hospital 1978 (Osler Medical Service)

Fellowship, Rheumatology Hospital for Special Surgery 1980 (Research )

2009 -To Present Attending Physician (Rheumatology Section, Cincinnati VAMC) and Volunteer Professor of Medicine (Division of Immunology and Rheumatology, University of Cincinnati), Cincinnati, OH

1997 -2008 Senior Medical Director, Musculoskeletal and Bone Research, Department of Worsldwide Clinical Development, Procter & Gamble Pharmaceuticals, Cincinnati, OH

1988 -1997 Senior Vice President for Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America, Washington, DC

1984 -1987 Associate Dean for Strategic Planning, Georgetown University School of Medicine,

1981 -1983 Deputy Assistant Secretary of Defense (Health Affairs), Department of Defense, Washington, DC

1980 -1981 Assistant Professor of Medicine, Georgetown University School of Medicine,

Clinical trials, Clinical Pharamcology, Drug Utiliztion, Verteran's Health Outcomes, Osteoarthritis, Rheumatoid Arthritis.

Peer Reviewed Publications

Katyal, Nakul; George, Pravin; Nattanamai, Premkumar; Raber, Larry N; Beary, Jonathan M; Newey, Christopher R (2018. ) Improvement in Sonographic Vasospasm Following Intravenous Milrinone in a Subarachnoid Hemorrhage Patient with Normal Cardiac Function.Cureus, , 10 (7 ) ,e2916

Katyal, Nakul; Narula, Naureen; George, Pravin; Nattanamai, Premkumar; Newey, Christopher R; Beary, Jonathan M (2018. ) Delayed Post-hypoxic Leukoencephalopathy: A Case Series and Review of the Literature.Cureus, , 10 (4 ) ,e2481

Katyal, Nakul; Taqui, Ather M; Tepper, Deborah; Beary, Jonathan M; Newey, Christopher R (2018. ) Fulminant Herpes Simplex Virus Type I Encephalitis Despite Maximal Medical Therapy.Cureus, , 10 (4 ) ,e2467

Katyal, Nakul; Newey, Christopher R; George, Pravin; Nattanamai, Premkumar; Beary, Jonathan M; Ardelt, Agnieszka; Vellipuram, Anantha (2018. ) Somatosensory Evoked Potentials as a Tool to Evaluate Brainstem Herniation in the Neuroscience Intensive Care Unit.Cureus, , 10 (4 ) ,e2443

Mullaguri, Naresh; Katyal, Nakul; Sarwal, Aarti; Beary, Jonathan M; George, Pravin; Karthikeyan, Naresh; Nattanamai, Premkumar; Newey, Christopher R (2017. ) Pitfall in Pupillometry: Exaggerated Ciliospinal Reflex in a Patient in Barbiturate Coma Mimicking a Nonreactive Pupil.Cureus, , 9 (12 ) ,e2004

McClung, M R; Zanchetta, J R; Racewicz, A; Roux, C; Benhamou, C-L; Man, Z; Eusebio, R A; Beary, J F; Burgio, D E; Matzkin, E; Boonen, S; Delmas, P (2013. ) Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, , 24 (1 ) ,293-9

Ste-Marie, Louis-Georges; Brown, Jacques P; Beary, John F; Matzkin, Ellen; Darbie, Lynn M; Burgio, David E; Racewicz, Artur J (2009. ) Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study.Clinical therapeutics, , 31 (2 ) ,272-85

Garnero, P; Aronstein, W S; Cohen, S B; Conaghan, P G; Cline, G A; Christiansen, C; Beary, J F; Meyer, J M; Bingham, C O (2008. ) Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial.Osteoarthritis and cartilage, , 16 (6 ) ,660-6

Raynauld, J-P; Martel-Pelletier, J; Berthiaume, M-J; Abram, F; Choquette, D; Haraoui, B; Beary, J F; Cline, G A; Meyer, J M; Pelletier, J-P (2008. ) Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period.Annals of the rheumatic diseases, , 67 (5 ) ,683-8

Delmas, Pierre D; McClung, Michael R; Zanchetta, José R; Racewicz, Artur; Roux, Christian; Benhamou, Claude-Laurent; Man, Zulema; Eusebio, Rachelle A; Beary, John F; Burgio, David E; Matzkin, Ellen; Boonen, Steven (2008. ) Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis.Bone, , 42 (1 ) ,36-42

Krzeski, Piotr; Buckland-Wright, Chris; Bálint, Géza; Cline, Gary A; Stoner, Karen; Lyon, Robert; Beary, John; Aronstein, William S; Spector, Tim D (2007. ) Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study.Arthritis research & therapy, , 9 (5 ) ,R109

Pelletier, Jean-Pierre; Raynauld, Jean-Pierre; Berthiaume, Marie-Josée; Abram, François; Choquette, Denis; Haraoui, Boulos; Beary, John F; Cline, Gary A; Meyer, Joan M; Martel-Pelletier, Johanne (2007. ) Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study.Arthritis research & therapy, , 9 (4 ) ,R74

Bingham, Clifton O; Buckland-Wright, J Chris; Garnero, Patrick; Cohen, Stanley B; Dougados, Maxime; Adami, Silvano; Clauw, Daniel J; Spector, Timothy D; Pelletier, Jean-Pierre; Raynauld, Jean-Pierre; Strand, Vibeke; Simon, Lee S; Meyer, Joan M; Cline, Gary A; Beary, John F (2006. ) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.Arthritis and rheumatism, , 54 (11 ) ,3494-507

Beary, John F (2006. ) Food and Drug Administration centennial: recognizing the guardians of our drug supply.Arthritis and rheumatism, , 54 (10 ) ,3374

O'Connor, Annette M; McKean, James D; Beary, John H; Brockus, Susan L (2006. ) Prevalence of exposure to Salmonella spp in finishing swine marketed in Iowa.American journal of veterinary research, , 67 (5 ) ,829-33

Raynauld, Jean-Pierre; Martel-Pelletier, Johanne; Berthiaume, Marie-Josée; Beaudoin, Gilles; Choquette, Denis; Haraoui, Boulos; Tannenbaum, Hyman; Meyer, Joan M; Beary, John F; Cline, Gary A; Pelletier, Jean-Pierre (2006. ) Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes.Arthritis research & therapy, , 8 (1 ) ,R21

Cline, G A; Meyer, J M; Stevens, R; Buckland-Wright, C; Peterfy, C; Beary, John F (2006. ) Comparison of fixed flexion, fluoroscopic semi-flexed and MTP radiographic methods for obtaining the minimum medial joint space width of the knee in longitudinal osteoarthritis trials.Osteoarthritis and cartilage, , 14 Suppl A ,A32-6

Spector, Tim D; Conaghan, Philip G; Buckland-Wright, J Christopher; Garnero, Patrick; Cline, Gary A; Beary, John F; Valent, David J; Meyer, Joan M (2005. ) Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173].Arthritis research & therapy, , 7 (3 ) ,R625-33

Beary, J F (2001. ) Joint structure modification in osteoarthritis: development of SMOAD drugs.Current rheumatology reports, , 3 (6 ) ,506-12

Beary, J F (1996. ) Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view.Journal of general internal medicine, , 11 (10 ) ,635-6

Beary, J F (1995. ) Inappropriate drug prescribing.JAMA, , 273 (6 ) ,455-6; author reply

Beary, J F (1994. ) The CERT concept: an industry perspective.Clinical pharmacology and therapeutics, , 56 (6 Pt 1 ) ,693-7

Beary, J F; Eaton, C R; Wierenga, D E (1993. ) Basic research and the cost of health care.Science (New York, N.Y.), , 262 (5138 ) ,1358

Beary, J F (1992. ) Pharmaceutical ads in journals. Annals of internal medicine, , 117 (7 ) ,616; author reply 61

Beary, J F; Eaton, C R (1992. ) Chirality and drug development.Science (New York, N.Y.), , 257 (5067 ) ,145

Beary, J F; Cleveland, C B (1992. ) DPS--the PMA perspective. American pharmacy, , NS32 (5 ) ,6, 8

Beary, J F (1992. ) Chirality and drug development.Lancet (London, England), , 339 (8791 ) ,495

Beary, J F (1990. ) New drug and biologic product approvals in 1989.Southern medical journal, , 83 (11 ) ,1289-94

Beary, J F (1990. ) Geriatric medications in the pipeline.Health affairs (Project Hope), , 9 (3 ) ,157-60

Beary, J F (1989. ) New drug approvals in 1988.Southern medical journal, , 82 (8 ) ,995-8

Brett, A S; Phillips, M; Beary, J F (1986. ) Predictive power of the polygraph: can the "lie detector" really detect liars?.Lancet (London, England), , 1 (8480 ) ,544-7

Beary, J F (1986. ) The polygraph: does it really detect lies? .American family physician, , 33 (3 ) ,98, 100

White, K B; Beary, J F (1986. ) Illegible handwritten medical records.The New England journal of medicine, , 314 (6 ) ,390-1

D'Angelo, L J; Beary, J F; Stair, T (1984. ) Tetanus mimicking "pseudotetanus".Southern medical journal, , 77 (8 ) ,1052-3

Beary, J F; Walter, L J; Johns, J H (1984. ) Leading causes of death for active duty military personnel. Military medicine, , 149 (6 ) ,316-7

Beary, J F (1984. ) Strategic planning: military medicine in the eighties. Military medicine, , 149 (4 ) ,181-3

Beary, J F (1983. ) Federal medical chiefs on progress and planning. Department of Defense. Military medicine, , 148 (11 ) ,857-63

Armstrong, P C; Beary, J F (1983. ) Office of the Assistant Secretary of Defense for Health Affairs: a history. Military medicine, , 148 (8 ) ,637-43

Nazzaro, J T; Beary, J F (1983. ) Benefits of a computerized pharmacy.JAMA, , 249 (24 ) ,3302-3

Beary, J F (1983. ) Medical readiness DoD's main goal. U. S. medicine, , 19 (2 ) ,9-12

Beary, J F (1982. ) Federal Medical Chiefs on progress and plans. Department of defense. Military medicine, , 147 (11 ) ,943-8

Beary, J F; Bisgard, J C; Armstrong, P C (1982. ) The Civilian-Military Contingency Hospital System.The New England journal of medicine, , 306 (12 ) ,738-40

Kimberly, R P; Lockshin, M D; Sherman, R L; Beary, J F; Mouradian, J; Cheigh, J S (1981. ) "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine, , 60 (4 ) ,277-87

Beary, J; Gilbert, S (1981. ) Coping with the "bashful bladder" syndrome.Lancet (London, England), , 1 (8235 ) ,1429-30

Beary, J F (1979. ) Mercury in sperm whale meat.Science (New York, N.Y.), , 206 (4424 ) ,1260

Beary, J F (1979. ) Gout: diagnosis and therapy. ONA journal, , 6 (8 ) ,313-7

Beary, J F; Summer, W R; Bulkley, B H (1979. ) Postpartum acute myocardial infarction: a rare occurrence of uncertain etiology.The American journal of cardiology, , 43 (1 ) ,158-61

Beary, J F (1978. ) Tobacco subsidies.The New England journal of medicine, , 298 (13 ) ,749

Beary, J F (1978. ) Pediatric injury and the steel jaw trap.JAMA, , 239 (10 ) ,931

Beary, J F (1977. ) Pseudoephedrine producing postural hypotension in a pilot. Aviation, space, and environmental medicine, , 48 (4 ) ,369

Beary, J F; Fortuin, N J (1974. ) Practolol for sinus tachycardia in asthma.Annals of internal medicine, , 81 (3 ) ,405

Beary, J F; Benson, H A simple psychophysiologic technique which elicits the hypometabolic changes of the relaxation response.Psychosomatic medicine, , 36 (2 ) ,115-20

Benson, H; Beary, J F; Carol, M P (1974. ) The relaxation response.Psychiatry, , 37 (1 ) ,37-46

Beary J.;Siegfried J.;Tavares R. (10-14-1998. ) US drug and biologic approvals in 1997.Drug Development Research, , 44 (2-3 ) ,114-129

Beary J.;Robillard L.;Woollett G.;Siegfried J.;White T.;Shriver D. (04-01-1997. ) U.S. drug and biological approvals in 1996.Drug Development Research, , 40 (4 ) ,275-291

Beary J.;Duchaine C.;Rhein R. (04-01-1996. ) U.S. Drug and biologic approvals in 1994-1995.Drug Development Research, , 37 (4 ) ,197-207

Beary J. (01-01-1994. ) In Reply: More Conflicts of Interest: Review Articles Sponsored by the Pharmaceutical Industry.JAMA: The Journal of the American Medical Association, , 272 (16 ) ,1254

Beary J.;Robert Eaton C.;Copmann T.;Wierenga D. (01-01-1994. ) U.S. drug and biologic product approvals during 1993.Drug Development Research, , 32 (3 ) ,127-133

Beary J.;Eaton C.;Copmann T.;Wierenga D. (12-20-1993. ) USA drug and biologic product approvals during 1992 .Journal of Pharmaceutical Medicine, , 3 (2 ) ,101-109

Beary J.;Wierenga D.;Copmann T. (01-01-1992. ) USA drug and biological product approvals during 1990 .Journal of Pharmaceutical Medicine, , 2 (1 ) ,59-65

Beary J.;Wierenga D.;Copmann T.;Eaton C. (01-01-1992. ) USA drug and biologic product approvals during 1991 .Journal of Pharmaceutical Medicine, , 2 (3 ) ,175-182

Beary J.;Angel J.;Liebman M.;Lexchin J.;Noble R.;Agzarian A.;Krinsky D.;Wilkes M.;Doblin B.;Shapiro M. (01-01-1992. ) Pharmaceutical ads in journals [1].Annals of Internal Medicine, , 117 (7 ) ,616-619

Huseby J.;Anderson P.;Beary J. (08-22-1991. ) Confusion about Drug Names.New England Journal of Medicine, , 325 (8 ) ,588-589

Beary J. (01-01-1990. ) Directions in research for Alzheimer's treatments .Hospital Pharmacy, , 25 (6 ) ,593-594

2003 Vicennial Service Award Georgetown University

1997 Lifetime Achievement Award American Academy of Pharmaceutical Physicians

2001 Honorary Member 6th Naval Beach Battalion (D-Day)

1997 Navy & Marine Corps Commendation Medal

1991 National Defense Service Medal (Navy)

1984 -To Present Who's Who in America

1983 Distinguished Public Service Medal Department of Defense

1979 New York Arthiritis Foundation Research Award

1973-1974 Intern, Osler Medical Service, Johns Hopkins Hospital, , Maryland, MD

1977-1978 Resident, Osler Medical Service, Johns Hopkins Hospital, , Baltimore, MD

1978-1980 Research Fellow, Rheumatology, Hospital for Special Surgery, , New York, NY

Rheumatologist; clinical pharmacologist; veterans administration

Academic - Health Professions Building
3255 Eden Avenue
Cincinnati  Ohio, 45267-0563
Phone: 513-558-4701
Fax: 513-558-3799
john.beary@uc.edu